ArticleFrontiers in oncology2022

Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy.

Seijiro Hamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.